PTX 0.00% 4.5¢ prescient therapeutics limited

Ann: Encouraging data from PTX-200 ovarian cancer trial, page-4

  1. 15,728 Posts.
    lightbulb Created with Sketch. 1793
    positive interim data from the Phase 1b safety study of PTX-
    200 in women with recurrent or persistent platinum resistant ovarian cancer, with acceptable
    safety and 80% of women exhibiting disease control (being partial response or stable disease)
 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
(20min delay)
Last
4.5¢
Change
0.000(0.00%)
Mkt cap ! $36.23M
Open High Low Value Volume
4.4¢ 4.5¢ 4.3¢ $19.18K 438.9K

Buyers (Bids)

No. Vol. Price($)
1 9412 4.4¢
 

Sellers (Offers)

Price($) Vol. No.
4.5¢ 385806 6
View Market Depth
Last trade - 16.10pm 25/07/2024 (20 minute delay) ?
PTX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.